SBT_New August 2022 LOGO
Standard BioTools Reports Third Quarter and Year-to-Date 2023 Financial Results
07 nov. 2023 16h00 HE | Standard BioTools Inc.
Year-to-date revenue growth, gross margin expansion and operating expense reduction are testament to continued execution against financial objectivesPlanned merger with SomaLogic activates strategic...
SBT_New August 2022 LOGO
Standard BioTools to Present at the Jefferies London Healthcare Conference
02 nov. 2023 08h30 HE | Standard BioTools Inc.
SOUTH SAN FRANCISCO, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health – today...
SBT_New August 2022 LOGO
Standard BioTools Announces Conference Call and Webcast of Third Quarter 2023 Financial Results on November 7, 2023
25 oct. 2023 08h30 HE | Standard BioTools Inc.
SOUTH SAN FRANCISCO, Calif., Oct. 25, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health – today...
Standard BioTools and SomaLogic to Combine in All-Stock Merger Creating a Diversified Leader in Life Sciences Tools
04 oct. 2023 08h00 HE | Standard BioTools Inc.; SomaLogic, Inc.
Activates Standard BioTools’ strategy to unlock value in underserved portion of $100 billion industry Establishes leading platform of multi-omic technologies with the highest throughput and highest...
SBT_New August 2022 LOGO
Standard BioTools Reports Second Quarter 2023 Financial Results
08 août 2023 16h05 HE | Standard BioTools Inc.
SOUTH SAN FRANCISCO, Calif., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB) (“Standard BioTools”, or the “Company”), driven by a bold purpose – Unleashing tools to accelerate...
SBT_New August 2022 LOGO
Standard BioTools to Participate in Upcoming Investor Conferences
26 juil. 2023 16h05 HE | Standard BioTools Inc.
SOUTH SAN FRANCISCO, Calif., July 26, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq: LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health – today...
SBT_New August 2022 LOGO
Standard BioTools Announces Conference Call and Webcast for Second Quarter 2023 Financial Results
25 juil. 2023 16h05 HE | Standard BioTools Inc.
SOUTH SAN FRANCISCO, Calif., July 25, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health – today...
SBT_New August 2022 LOGO
Standard BioTools to Participate in Upcoming Investor Conferences
14 juin 2023 07h30 HE | Standard BioTools Inc.
SOUTH SAN FRANCISCO, Calif., June 14, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq: LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health – today...
SBT_New August 2022 LOGO
Standard BioTools to Present at the Jefferies Healthcare Conference
25 mai 2023 16h05 HE | Standard BioTools Inc.
SOUTH SAN FRANCISCO, Calif., May 25, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health – today...
SBT_New August 2022 LOGO
Standard BioTools Announces NGS Library Preparation as an Upgrade on the X9 High-Throughput Genomics System
18 mai 2023 07h30 HE | Standard BioTools Inc.
SOUTH SAN FRANCISCO, Calif., May 18, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health – today...